KontRASt-01 Update: Safety and Efficacy of JDQ443 in KRAS G12C-Mutated Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC)

被引：1
|
作者：
Cassier, P. [1 ]
Dooms, C. [2 ]
Gazzah, A. [3 ]
Felip, E. [4 ,5 ]
Steeghs, N.
Rohrberg, K. S. [6 ]
De Braud, F. [7 ,8 ]
Solomon, B. [9 ]
Schuler, M. [10 ]
Tan, D. S. [11 ]
Yamamoto, N. [12 ]
Loong, H. H. F. [13 ]
Cho, B. C. [14 ]
Wolf, J. [15 ]
Lin, C. C. [16 ]
Negrao, M. V. [17 ]
Werner, L. [18 ]
Cui, X. [19 ]
Farago, A. F. [18 ]
DeMiguel, M. J. [20 ]
机构：
[1] Ctr Leon Berard, Lyon, France
[2] Univ Hosp Leuven, Leuven, Belgium
[3] Inst Gustave Roussy, Villejuif, France
[4] Vall dHebron Inst Oncol, Barcelona, Spain
[5] Netherlands Canc Inst, Amsterdam, Netherlands
[6] Copenhagen Univ Hosp, Dept Oncol, Rigshosp, Copenhagen, Denmark
[7] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[8] Univ Milan, Milan, Italy
[9] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[10] Univ Hosp Essen, West German Canc Ctr, Essen, Germany
[11] Natl Canc Ctr Singapore, Singapore, Singapore
[12] Natl Canc Ctr, Tokyo, Japan
[13] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Peoples R China
[14] Yonsei Univ, Coll Med, Seoul, South Korea
[15] Univ Hosp Cologne, Dept Internal Med 1, Ctr Integrated Oncol, Cologne, Germany
[16] Natl Taiwan Univ Hosp, Taipei, Taiwan
[17] MD Anderson Canc Ctr, Houston, TX USA
[18] Novartis Inst BioMed Res, Cambridge, MA USA
[19] Novartis Pharmaceut, E Hanover, NJ USA
[20] START CIOCC Hosp Univ HM Sanchinarro, Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
100
引用
收藏
页码：E4 / E5
页数：2
相关论文
共 50 条
  • [1] KontRASt-01 update: safety and efficacy of JDQ443 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC)
    Schuler, M.
    Cassier, P. A.
    Dooms, C.
    Gazzah, A.
    Felip, E.
    Steeghs, N.
    Rohrberg, K. S.
    De Braud, F.
    Solomon, B.
    Tan, D. S.
    Yamamoto, N.
    Loong, H. H.
    Cho, B. C.
    Wolf, J.
    Lin, C. -C
    Negrao, M.
    Werner, L.
    Cui, X.
    Farago, A. F.
    de Miguel, M. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 147 - 148
  • [2] KontRASt-01 update: Safety and efficacy of JDQ443 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC)
    Cassier, Philippe Alexandre
    Dooms, Christophe Alfons
    Gazzah, Anas
    Felip, Enriqueta
    Steeghs, Neeltje
    Rohrberg, Kristoffer Staal
    De Braud, Filippo G.
    Solomon, Benjamin J.
    Schuler, Martin H.
    Tan, Daniel Shao-Weng
    Yamamoto, Noboru
    Loong, Herbert H. F.
    Cho, Byoung Chul
    Wolf, Juergen
    Lin, Chia-Chi
    Negrao, Marcelo Vailati
    Werner, Lillian
    Cui, Xiaoming
    Farago, Anna F.
    de Miguel, Maria J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] KontRASt-01: Preliminary Safety and Efficacy of JDQ443+TNO155 in Patients with Advanced, KRAS G12C-Mutated Solid Tumors
    Negrao, M. V.
    Cassier, P. A.
    Solomon, B.
    Schuler, M.
    Rohrberg, K.
    Cresta, S.
    Dooms, C.
    Tan, D. S. W.
    Loong, H. H-F.
    Amatu, A.
    Assmann, K. Krueger
    Fairchild, L.
    Sansregret, L.
    Fan, L.
    Farago, A. F.
    Cho, B. C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S117 - S118
  • [4] KontRASt-01: A Phase Ib/II Dose Escalation Study of JDQ443 in Patients with advanced KRAS G12C mutated solid Tumors
    Schuler, M.
    Tan, D. S.
    Shimizu, T.
    Solomon, B.
    Heist, R. S.
    de Miguel, M.
    Gazzah, A.
    Wermke, M.
    Dooms, C.
    Loong, H. H.
    Steeghs, N.
    Felip, E.
    Steuer, C. E.
    Van Cutsem, E.
    Soo, R. A.
    Jaeger, A.
    Kim, J.
    Xu, K.
    Cui, X.
    Burks, H.
    Farago, A. F.
    Cassier, P. A.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 29 - 29
  • [5] Safety and efficacy of HS-10370 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC)
    Dong, Xiaorong
    Meng, Xiangjiao
    Zhang, Yan
    Wang, Yan
    Chen, Jianhua
    Han, Liang
    Wang, Qiming
    Lin, Zhong
    Wei, Hongying
    Lin, Siheng
    Li, Chuan
    Wu, Qiong
    CANCER RESEARCH, 2024, 84 (07)
  • [6] KontRASt-02: A phase III trial investigating the efficacy and safety of the KRASG12C inhibitor JDQ443 vs docetaxel in patients with previously treated, locally advanced or metastatic, KRAS G12C-mutated NSCLC.
    Cappuzzo, Federico
    Castro, Gilberto
    Kang, Jin-Hyoung
    Wu, Yi-Long
    Brustugun, Odd Terje
    Cheema, Parneet Kaur
    Owonikoko, Taofeek K.
    Longin, Anne-Sophie
    Boran, Aislyn
    Duan, Jiawei
    Caparica, Rafael
    Loong, Herbert H. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Efficacy and safety outcomes in patients receiving sotorasib for advanced KRAS G12C-mutated non-small cell lung cancer
    Milner-Watts, Charlotte
    O'Sullivan, Hazel
    Stewart, James
    Idaikkadar, Praveena
    Tokaca, Nadza
    Davidson, Michael
    Yousaf, Nadia
    Bhosle, Jaishree
    Popat, Sanjay
    O'Brien, Mary
    Minchom, Anna
    LUNG CANCER, 2023, 178 : S31 - S32
  • [8] Sotorasib in KRAS G12C-mutated non-small cell lung carcinoma
    Lorenz, Judith
    PNEUMOLOGIE, 2023, 77 (11): : 846 - 846
  • [9] KontRASt-02: A Phase III Trial Investigating the Efficacy and Safety of the KRASG12C Inhibitor JDQ443 vs. Docetaxel in Patients with Previously Treated, Locally Advanced or Metastatic, KRAS G12C-Mutated NSCLC
    Cappuzzo, F.
    Castro Junior, G.
    Kang, J. H.
    Wu, Y. L.
    Brustugun, O. T.
    Cheema, P. K.
    Owonikoko, T. K.
    Longin, A. S.
    Duan, J.
    Caparica, R.
    Loong, H. H. F.
    Chan, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : E14 - E14
  • [10] Early-stage KRAS G12C-mutated non-small cell lung cancer (NSCLC) in Australia.
    Mitchell, Paul
    Dharmaraj, Devisri
    Knight, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345